BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 24674692)

  • 1. Systemic neutralization of IL-17A significantly reduces breast cancer associated metastasis in arthritic mice by reducing CXCL12/SDF-1 expression in the metastatic niches.
    Roy LD; Sahraei M; Schettini JL; Gruber HE; Besmer DM; Mukherjee P
    BMC Cancer; 2014 Mar; 14():225. PubMed ID: 24674692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Collagen induced arthritis increases secondary metastasis in MMTV-PyV MT mouse model of mammary cancer.
    Roy LD; Ghosh S; Pathangey LB; Tinder TL; Gruber HE; Mukherjee P
    BMC Cancer; 2011 Aug; 11():365. PubMed ID: 21859454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast-cancer-associated metastasis is significantly increased in a model of autoimmune arthritis.
    Das Roy L; Pathangey LB; Tinder TL; Schettini JL; Gruber HE; Mukherjee P
    Breast Cancer Res; 2009; 11(4):R56. PubMed ID: 19643025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arthritis augments breast cancer metastasis: role of mast cells and SCF/c-Kit signaling.
    Das Roy L; Curry JM; Sahraei M; Besmer DM; Kidiyoor A; Gruber HE; Mukherjee P
    Breast Cancer Res; 2013 Apr; 15(2):R32. PubMed ID: 23577751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skeletal localization and neutralization of the SDF-1(CXCL12)/CXCR4 axis blocks prostate cancer metastasis and growth in osseous sites in vivo.
    Sun YX; Schneider A; Jung Y; Wang J; Dai J; Wang J; Cook K; Osman NI; Koh-Paige AJ; Shim H; Pienta KJ; Keller ET; McCauley LK; Taichman RS
    J Bone Miner Res; 2005 Feb; 20(2):318-29. PubMed ID: 15647826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel CXCR4 antagonist counteracts paradoxical generation of cisplatin-induced pro-metastatic niches in lung cancer.
    Bertolini G; Cancila V; Milione M; Lo Russo G; Fortunato O; Zaffaroni N; Tortoreto M; Centonze G; Chiodoni C; Facchinetti F; Pollaci G; Taiè G; Giovinazzo F; Moro M; Camisaschi C; De Toma A; D'Alterio C; Pastorino U; Tripodo C; Scala S; Sozzi G; Roz L
    Mol Ther; 2021 Oct; 29(10):2963-2978. PubMed ID: 34023505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of CXCR4 by SDF-KDEL in SBC-5 cells inhibits their migration in vitro and organ metastasis in vivo.
    Ma N; Pang H; Shen W; Zhang F; Cui Z; Wang J; Wang J; Liu L; Zhang H
    Int J Mol Med; 2015 Feb; 35(2):425-32. PubMed ID: 25504108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of chemokine receptor 4/stromal cell-derived factor 1 system during osteosarcoma tumor progression.
    Perissinotto E; Cavalloni G; Leone F; Fonsato V; Mitola S; Grignani G; Surrenti N; Sangiolo D; Bussolino F; Piacibello W; Aglietta M
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):490-7. PubMed ID: 15701832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-24 inhibits lung cancer cell migration and invasion by disrupting the SDF-1/CXCR4 signaling axis.
    Panneerselvam J; Jin J; Shanker M; Lauderdale J; Bates J; Wang Q; Zhao YD; Archibald SJ; Hubin TJ; Ramesh R
    PLoS One; 2015; 10(3):e0122439. PubMed ID: 25775124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LRP6 Ectodomain Prevents SDF-1/CXCR4-Induced Breast Cancer Metastasis to Lung.
    Zhang J; Chen J; Wo D; Yan H; Liu P; Ma E; Li L; Zheng L; Chen D; Yu Z; Liang C; Peng J; Ren DN; Zhu W
    Clin Cancer Res; 2019 Aug; 25(15):4832-4845. PubMed ID: 31010839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-X-C motif chemokine 12/C-X-C chemokine receptor type 7 signaling regulates breast cancer growth and metastasis by modulating the tumor microenvironment.
    Wani N; Nasser MW; Ahirwar DK; Zhao H; Miao Z; Shilo K; Ganju RK
    Breast Cancer Res; 2014 May; 16(3):R54. PubMed ID: 24886617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GM-CSF but not IL-17 is critical for the development of severe interstitial lung disease in SKG mice.
    Shiomi A; Usui T; Ishikawa Y; Shimizu M; Murakami K; Mimori T
    J Immunol; 2014 Jul; 193(2):849-59. PubMed ID: 24951817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloid-derived suppressor cell depletion therapy targets IL-17A-expressing mammary carcinomas.
    Dawod B; Liu J; Gebremeskel S; Yan C; Sappong A; Johnston B; Hoskin DW; Marshall JS; Wang J
    Sci Rep; 2020 Aug; 10(1):13343. PubMed ID: 32770025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the chemokine receptor CXCR7 in CXCR4-expressing human 143B osteosarcoma cells enhances lung metastasis of intratibial xenografts in SCID mice.
    Brennecke P; Arlt MJ; Muff R; Campanile C; Gvozdenovic A; Husmann K; Holzwarth N; Cameroni E; Ehrensperger F; Thelen M; Born W; Fuchs B
    PLoS One; 2013; 8(9):e74045. PubMed ID: 24040160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stromal cell-derived factor 1/CXCR4 signaling is critical for the recruitment of mesenchymal stem cells to the fracture site during skeletal repair in a mouse model.
    Kitaori T; Ito H; Schwarz EM; Tsutsumi R; Yoshitomi H; Oishi S; Nakano M; Fujii N; Nagasawa T; Nakamura T
    Arthritis Rheum; 2009 Mar; 60(3):813-23. PubMed ID: 19248097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCL12 loaded-dermal filler captures CXCR4 expressing melanoma circulating tumor cells.
    Ieranò C; D'Alterio C; Giarra S; Napolitano M; Rea G; Portella L; Santagata A; Trotta AM; Barbieri A; Campani V; Luciano A; Arra C; Anniciello AM; Botti G; Mayol L; De Rosa G; Pacelli R; Scala S
    Cell Death Dis; 2019 Jul; 10(8):562. PubMed ID: 31332163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of CXCL12 secretion to invasion of breast cancer cells.
    Boimel PJ; Smirnova T; Zhou ZN; Wyckoff J; Park H; Coniglio SJ; Qian BZ; Stanley ER; Cox D; Pollard JW; Muller WJ; Condeelis J; Segall JE
    Breast Cancer Res; 2012 Feb; 14(1):R23. PubMed ID: 22314082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of SDF-1-CXCR4 signaling on microRNA expression and tumorigenesis in estrogen receptor-alpha (ER-α)-positive breast cancer cells.
    Rhodes LV; Bratton MR; Zhu Y; Tilghman SL; Muir SE; Salvo VA; Tate CR; Elliott S; Nephew KP; Collins-Burow BM; Burow ME
    Exp Cell Res; 2011 Nov; 317(18):2573-81. PubMed ID: 21906588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models.
    Gravina GL; Mancini A; Muzi P; Ventura L; Biordi L; Ricevuto E; Pompili S; Mattei C; Di Cesare E; Jannini EA; Festuccia C
    Prostate; 2015 Sep; 75(12):1227-46. PubMed ID: 26073897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stromal derived factor-1 (SDF-1/CXCL12) and CXCR4 in renal cell carcinoma metastasis.
    Pan J; Mestas J; Burdick MD; Phillips RJ; Thomas GV; Reckamp K; Belperio JA; Strieter RM
    Mol Cancer; 2006 Nov; 5():56. PubMed ID: 17083723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.